Krastev and colleagues1 should be commended for their carefully matched cohort study that supports the long-term oncological safety of postmastectomy autologous fat transfer (AFT). It is currently recommended that, before undergoing a mastectomy, patients should have the opportunity to meet with a plastic surgeon to discuss their reconstructive options. Patients are then offered the standard implant-based or tissue flap–based reconstructions. Autologous fat transfer is rarely mentioned.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Khouri KS, Khouri RK, Khouri RK. The Third Postmastectomy Reconstruction Option—Autologous Fat Transfer. JAMA Surg. 2019;154(1):63–64. doi:10.1001/jamasurg.2018.3757
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: